- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 7, 2025 | 5M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 4.99M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 4.99M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 4.91M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 4.89M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $0 |
| Capex | Q3 2025 · Sep 30, 2024 | $132K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$55.12M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$63.09M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $0 |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $10.95M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $56.39M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $107.75M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $78.87M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2023 | $174.56M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$59.54M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$53.15M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$30.87M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$9.51M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $1.05M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $8.43M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $27.99M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $36.9M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $43.27M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $62.46M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $122.22M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $154.17M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $59.99M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $136.9M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $62.69M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $144.66M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.51 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$11.22 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$2.34 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$11.27 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.51 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$11.22 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$2.34 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$11.27 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $6.3M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $22.64M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $9.86M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $31.93M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $12.18M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $46.74M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $14.8M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $50.73M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$7.55M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$55.96M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$24.3M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$24.12M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$11.5M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$55.08M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$24.27M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$19.31M |
| Revenue | Q3 2025 · Sep 30, 2025 | $11.01M |
| Revenue | Q3 2025 · Sep 30, 2025 | $16.82M |
| Revenue | Q3 2025 · Sep 30, 2024 | $12.6M |
| Revenue | Q3 2025 · Sep 30, 2024 | $24.14M |